Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Does renin angiotensin system blockade deserve preferred status over other anti-hypertensive medications for the treatment of people with diabetes?

Literature DB >> 27294098

Does renin angiotensin system blockade deserve preferred status over other anti-hypertensive medications for the treatment of people with diabetes?

Joshua I Barzilay¹, Paul K Whelton¹, Barry R Davis¹.

Abstract

Entities: Disease Gene Species

Year: 2016 PMID： 27294098 PMCID： PMC4885898 DOI： 10.21037/atm.2016.05.24

Source DB: PubMed Journal: Ann Transl Med ISSN： 2305-5839

× No keyword cloud information.

36 in total

1. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors: S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal: N Engl J Med Date: 2000-01-20 Impact factor: 91.245

Review 2. Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: a pooled analysis.

Authors: George Jerums; Sianna Panagiotopoulos; Erosha Premaratne; David A Power; Richard J MacIsaac
Journal: Am J Nephrol Date: 2008-02-19 Impact factor: 3.754

3. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.

Authors: William J Elliott; Peter M Meyer
Journal: Lancet Date: 2007-01-20 Impact factor: 79.321

4. Effect of ramipril on the incidence of diabetes.

Authors: Jackie Bosch; Salim Yusuf; Hertzel C Gerstein; Janice Pogue; Patrick Sheridan; Gilles Dagenais; Rafael Diaz; Alvaro Avezum; Fernando Lanas; Jeffrey Probstfield; George Fodor; Rury R Holman
Journal: N Engl J Med Date: 2006-09-15 Impact factor: 91.245

5. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

Authors: H H Parving; H Lehnert; J Bröchner-Mortensen; R Gomis; S Andersen; P Arner
Journal: N Engl J Med Date: 2001-09-20 Impact factor: 91.245

6. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors:
Journal: Lancet Date: 2000-01-22 Impact factor: 79.321

Review 7. How to protect the kidney in diabetic patients: with special reference to IDDM.

Authors: C E Mogensen
Journal: Diabetes Date: 1997-09 Impact factor: 9.461

8. Angiotensin-converting-enzyme inhibition in stable coronary artery disease.

Authors: Eugene Braunwald; Michael J Domanski; Sarah E Fowler; Nancy L Geller; Bernard J Gersh; Judith Hsia; Marc A Pfeffer; Madeline M Rice; Yves D Rosenberg; Jean L Rouleau
Journal: N Engl J Med Date: 2004-11-07 Impact factor: 91.245

Review 9. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.

Authors: Juan P Casas; Weiliang Chua; Stavros Loukogeorgakis; Patrick Vallance; Liam Smeeth; Aroon D Hingorani; Raymond J MacAllister
Journal: Lancet Date: 2005-12-10 Impact factor: 79.321

3. Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modifications.

Authors: Almesh Kadakol; Vajir Malek; Santosh Kumar Goru; Anuradha Pandey; Anil Bhanudas Gaikwad
Journal: Indian J Pharmacol Date: 2017 Sep-Oct Impact factor: 1.200

3 in total